Lovastatin and Other HMG‐CoA Reductase Inhibitors
- 1 November 1989
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 29 (11), 975-982
- https://doi.org/10.1002/j.1552-4604.1989.tb03264.x
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)The American Journal of Cardiology, 1989
- New Horizons in Combination Drug Therapy for HypercholesterolemiaJMIR AI, 1989
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- LovastatinDrugs, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemiaAtherosclerosis, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.JCI Insight, 1984